Blog

UBS today provided a forecast for the USD/CNY exchange rate, projecting it to reach 7.5 by the first half of 2025. This prediction comes amid ongoing trade tensions between the...

In 2020, Lego launched its adult-focused category. Adults also introduce kids to Lego, making them a group critical to the Danish toymaker.

The recently released report on Building Permits has caught the attention of economists and investors alike, revealing a significant increase that may hint at a robust state of the...

MOSCOW (Reuters) -Inflationary expectations among Russian households for the year ahead rose to 13.9% in December, the highest value since the start of the year, from 13.4% in...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. The trial will enroll 64 patients with moderate to severe atopic dermatitis who previously failed one prior topical or systemic therapy. These doses were selected based on the company’s prior experience evaluating soquelitinib in T-cell lymphoma patients. The company is reporting complete results from Cohort 1 of the trial, which inc

Tender rejection rate rises as holidays approach The tender rejection rate has risen steadily since early October despite tender volume declining. That implies that capacity is leaving the market, which […] The post Freight market shows additional signs of recovery appeared first on FreightWaves.

Cryptocurrencies pulled back after a big run yesterday and as the Federal Reserve sets to conclude its final meeting of the year, likely with a rate cut of 25 basis points. The meme tokens Dogecoin (CRYPTO: DOGE) and Shiba Inu (CRYPTO: SHIB) traded 4.3% and 4.6% lower, respectively. Cryptocurrencies, and more specifically Bitcoin, have rallied this week after President-elect Donald Trump said he would like to create a strategic Bitcoin reserve like the country's strategic oil reserve.

On Wednesday, Merck & Co Inc (NYSE:MRK) and Hansoh Pharma, a Chinese biopharmaceutical company, entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist. Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture, and commercialize HS-10535. Hansoh Pharma will receive an upfront payment of $112 million and is eligible to receive up to $1.9 billion in milestone payments

(Bloomberg) -- A whopping 1130% rally in the shares of a Brazilian waste management company is drawing the attention of the country’s stock exchange operator. Most Read from BloombergNYPD Car Chases Are Becoming More Frequent — and More DangerousB3 SA, the company behind Brazil’s stock exchange, requested clarification on “atypical fluctuations” in the shares of Ambipar Participacoes e Empreendimentos SA that took place between Dec. 11 and 13, according to a note. On those days, the stock surged

A new report identifies data content management as the primary driver of growth in the pharmaceuticals market.